abstract |
The present invention relates to an optimized chimeric antigen receptor (CAR) capable of targeting a variety of cancer types and to genetically modified cells expressing the same.nMore specifically, the CAR has an optimized linker length that facilitates targeting and lysis of a wide range of cancer cell types by the CAR expressing T cells. |